This inventor holds 1 USPTO granted patent. Top assignee: American Cyanamid Company. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Steven M Baker: Innovator in Pertussis Holotoxin Research
Introduction
Steven M Baker is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biotechnology, particularly in the study of Bordetella pertussis, the bacterium responsible for whooping cough. His work has implications for vaccine development and understanding bacterial pathogenesis.
Latest Patents
Steven M Baker holds a patent titled "Genes for the export of pertussis holotoxin." This invention relates to a cloned region of the Bordetella pertussis genome located 3' of the ptx operon. It encodes factors required for the expression, assembly, and secretion of pertussis holotoxin. The patent also describes methods for obtaining increased levels of holotoxin production using both homologous and heterologous hosts. He has 1 patent to his name.
Career Highlights
Baker has worked with the American Cyanamid Company, where he has been involved in groundbreaking research. His expertise in molecular biology and genetics has allowed him to contribute to advancements in the understanding of bacterial toxins.
Collaborations
One of his notable collaborators is Robert A Deich, with whom he has worked on various projects related to his research in pertussis holotoxin.
Conclusion
Steven M Baker's innovative work in the field of biotechnology has paved the way for further research and development in vaccine technology and bacterial pathogenesis. His contributions are invaluable to the scientific community and public health.